What is Etiometry?
Founded in 2010 and headquartered in Massachusetts, Etiometry specializes in advanced clinical decision-support software. The company's platform is engineered to empower clinicians in intensive care units (ICUs) by providing them with the data-driven tools necessary to make informed decisions regarding patient care and treatment protocols. Etiometry's technology aims to optimize patient outcomes by leveraging real-time data analytics within the critical care environment.
How much funding has Etiometry raised?
Etiometry has raised a total of $9.3M across 2 funding rounds:
Debt
$350K
Series A
$9M
Debt (2020): $350K with participation from PPP
Series A (2021): $9M led by SKK 9i Ventures and Shamrock Holdings
Key Investors in Etiometry
Shamrock Holdings
Shamrock Holdings is an investment firm established in 1978, primarily serving the investment needs of the Disney Family. The company emphasizes integrity, responsibility, and transparency in its operations and manages various real estate investment programs.
SKK 9i Ventures
SKK 9i Ventures is an investment entity that participated in Etiometry's Series A funding round. Further details on its investment focus are not publicly disclosed.
PPP
Public-Private Partnership
What's next for Etiometry?
The recent strategic investment signifies a pivotal moment for Etiometry, likely positioning the company for accelerated growth and further development of its innovative clinical decision-support solutions. This capital infusion is expected to bolster Etiometry's market presence and enable expansion into new healthcare verticals or enhancement of its existing product suite. The company's focus on data-based decision-making in critical care aligns with the broader healthcare industry's push towards digital transformation and improved patient outcomes.
See full Etiometry company page
